Applied MaterialsvsClinuvel Pharmaceuticals

AMAT and CUVL stock compared: price, dividend, valuation and results, from SEC filings.

AMAT

Applied Materials, Inc.

$302.55

Value $240B

-10.97%
AMAT's page

CUVL

Clinuvel Pharmaceuticals Limited

$4.66

Value $235M

-1.06%
CUVL's page

Applied Materials (AMAT) has a market value of $240B and Clinuvel Pharmaceuticals (CUVL) $235M. Over the last year, with dividends, AMAT moved +29.5% and CUVL -32.5%. The P/E is 25.9 for AMAT and 10.1 for CUVL. Dividend yield: AMAT 0.68%, CUVL 0.71%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMAT$240B

    CUVL$235M

    AMAT is 1,021 times CUVL

  • Revenue, 12 months

    AMAT$30.8B

    CUVL$64M

    AMAT is 479 times CUVL

  • Net income, 12 months

    AMAT$9.3B

    CUVL$23M

    AMAT is 400 times CUVL

  • Operating margin

    AMAT29.6%

    CUVL43.4%

    13.8 points apart

  • ROIC

    AMAT27.5%

    CUVL11.7%

    15.8 points apart

  • P/E

    AMAT25.9

    CUVL10.1

    AMAT is 2.6 times CUVL

  • Dividend yield

    AMAT0.7%

    CUVL0.7%

    About the same

  • 5-year return

    AMAT+110.3%

    CUVL-79.3%

    189.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMAT+110.3%

CUVL-79.3%

020040020222023202420252026
Returns by period
PeriodAMATWith dividendsCUVLWith dividends
1 year since November 19, 2025+29.5%Price +28.5%-32.5%Price -32.9%
3 years since November 20, 2023+103.1%+26.6% a yearPrice +98.1%-54.9%-23.3% a yearPrice -55.3%
5 years since November 19, 2021+110.3%+16.0% a yearPrice +101.5%-79.3%-27.0% a yearPrice -79.6%
10 years since November 21, 2016+974.3%+26.8% a yearPrice +864.1%-20.9%-2.3% a yearPrice -22.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMATApplied MaterialsCUVLClinuvel Pharmaceuticals

Valuation

AMATCUVL
Valuation
Price$302.55$4.66
Market value$240B$235M
Enterprise value (EV)$237B$61M
P/E25.910.1
P/E, 5-year median21.415.9
P/B9.41.3
EV/EBIT26.02.2
Free cash flow yield2.3%5.0%

Results and growth

AMATCUVL
Results and growth
Revenue, 12 months$30.8B$64M
Net income, 12 months$9.3B$23M
Free cash flow, 12 months$5.6B$12M
Earnings per share, 12 months$11.59$0.46
Revenue growth, year on year4.4%5.2%
Revenue growth a year, past+10.5%over 5 years+5.4%over 2 years
EPS growth a year, past+17.2%over 5 years+0.0%over 2 years

Margins and returns on capital

AMATCUVL
Margins and returns on capital
Gross margin49.4%82.9%
Operating margin29.6%43.4%
Net margin30.0%36.0%
ROIC27.5%11.7%
ROE41.7%12.3%

Balance sheet

AMATCUVL
Balance sheet
Cash$9.2B$174M
Total debt$7.3B$1.3M
Net debt / EBITDA-0.3-6.2
Interest cover33.0×–

Dividends and buybacks

AMATCUVL
Dividends and buybacks
Dividend yield0.7%0.7%
Dividend per share, 12 months$2.05$0.03
Dividend growth a year, past+15.4%over 5 years–
Buyback yield2.0%–
Shareholder yield2.7%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMAT or CUVL

Didn't find what you were looking for?

Ask us
Which is bigger, Applied Materials or Clinuvel Pharmaceuticals?

By market value, Applied Materials ($240B) is about 1,020.9 times Clinuvel Pharmaceuticals ($235M), at today's prices.

How did AMAT and CUVL stock do over the last 10 years?

Since November 21, 2016, AMAT's price moved +864.1% and CUVL's -22.3%. With dividends: AMAT +974.3% (+26.8% a year), CUVL -20.9% (-2.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMAT or CUVL?

The dividend yield at today's price is 0.68% for Applied Materials and 0.71% for Clinuvel Pharmaceuticals. Over the last twelve months they paid $2.05 and $0.03 per share.

What is the P/E of AMAT and CUVL?

At today's price, the P/E is 25.9 for AMAT and 10.1 for CUVL. The median of the last five years was 21.4 and 15.9, which shows where each stands against its own past.

Which has the higher profit margins, Applied Materials or Clinuvel Pharmaceuticals?

Over the last twelve months, the net margin was 30.0% for Applied Materials and 36.0% for Clinuvel Pharmaceuticals, and the operating margin 29.6% and 43.4%. Revenue was $30.8B and $64M.

Which is the better investment, Applied Materials or Clinuvel Pharmaceuticals?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.